According to Harvard Bioscience's latest financial reports the company's current earnings (TTM) are -HK$73.5 M. In 2023 the company made an earning of -HK$19.93 M an increase over its 2022 earnings that were of -HK$71.56 M.The earnings displayed on this page is the company's Pretax Income.